Vioxx Lawsuit

Canada Lawyers Represent Hundreds of Canadians Injured by Vioxx

Our law firm is handling hundreds of Vioxx claims on behalf of Canadians injured by Vioxx. Most of our clients suffered a heart attack or stroke while taking the drug.

For more information about the Vioxx lawsuit, we encourage you to read our Vioxx FAQ.

Greg Monforton Reacts to $4.85 Billion Vioxx Settlement

November 9, 2007—Greg Monforton today reacted to the U.S. $4.85 billion Vioxx settlement reached with Merck & Co.

Monforton’s office has fielded close to 4,000 inquiries from across Canada from people with concerns that they suffered injury by ingesting Vioxx.  Ultimately, Monforton agreed to take on over 300 individual cases involving Canadians from all provinces.  Monforton said that all of his firm’s Vioxx clients have suffered either heart attack or stroke, resulting in serious injuries and in many cases, death. 

Click here to read the full press release.

Greg Monforton Calls Merck Verdict "Fact Specific"

November 5, 2005—Greg Monforton called today's New Jersey jury verdict "a fact specific event." The plaintiff's integrity was viciously attacked by Merck, demonstrating that each case will be unique and tied specifically to its own facts.

The jury verdict in favor of Merck in no way hurts any of the cases that our law firm in prosecuting. The firm looks forward to litigating each and every case, one by one, if that is necessary.

The full press release further addresses our firm's response to this verdict.

Vioxx Award in Texas Good News for Canadian Lawsuits

August 19, 2005—A Texas jury returned a $253 million verdict against Merck after finding that Vioxx was responsible for the death of Robert Ernst. Ernst died suddenly of a heart attack after taking Vioxx for 8 months.

The jury likely was persuaded by documents dating back as far as 1999 that indicated company scientists had concerns about the cardiovascular safety of Vioxx. These documents are important as they demonstrate Merck knew of the risks of Vioxx and continued to market the drug despite these concerns.

Background Information on Vioxx Recall

Although the recall was announced on September 30, 2004, problems with the drug were evidence years before this announcement. Numerous clinical studies have led medical researchers to conclude that Vioxx presents a significant and unnecessary risk to patients.

In conjunction with Kaiser Permanente, the FDA conducted a study to evaluate the risks of Vioxx. The study, which analyzed data from more than 1.4 million people, found that Vioxx patients were at a three times greater risk of suffering a heart attack.

The delay in responding to important safety studies compromised the health of millions of people throughout Canada and worldwide. Merck & Co. could have acted proactively to warn consumers and doctors of the danger, but instead continued to aggressively market the dangerous drug.

If you have been injured by Vioxx, you may be entitled to compensation.

Vioxx Lawyers Canada

Greg Monforton and Partners is handling legal claims against Merck on behalf of Canadians injured by the arthritis drug Vioxx. We currently represent more than two hundred people who suffered heart attacks, blood clots and strokes after using Vioxx.

If you or a loved one has been injured as a result of Vioxx, we encourage you to contact us. We are representing clients throughout Canada in lawsuits against Merck.

For free answers to your questions about the Vioxx lawsuit, please complete our online form.

Contact Us

In the Press

Greg Monforton was featured in an article discussing the firm's involvement in Vioxx lawsuits on behalf of Canadian citizens.

The article, titled Hundreds of Vioxx Lawsuits Expected, appeared in CBC News.

Vioxx News

Vioxx Lawsuit

Our firm has compiled important information on the latest development in the Vioxx lawsuit.

We encourage you to visit the Vioxx news page for more details on the Vioxx recall and our efforts in representing hundreds of Canadians injured by Vioxx.